Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A scientist engineer's contribution to therapeutic discovery and development

Jennifer L Wilson1

  • 1Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.

Experimental Biology and Medicine (Maywood, N.J.)
|November 22, 2018
PubMed
Summary

No abstract available in PubMed .

Keywords:
Engineeringdrug developmentmolecular medicinepathwayspharmacodynamicssystems biologytherapeutic discovery

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Curated and Structure-Based Drug-Target Interactions Improve Underprediction of Drug Side Effects in Network Models.

Journal of chemical information and modeling·2026
Same author

Uncovering New Therapeutic Targets for Amyotrophic Lateral Sclerosis and Neurological Diseases Using Real-World Data.

Clinical pharmacology and therapeutics·2025
Same author

Preclinical side effect prediction through pathway engineering of protein interaction network models.

CPT: pharmacometrics & systems pharmacology·2024
Same author

Beta-2 adrenergic receptor agonism alters astrocyte phagocytic activity and has potential applications to psychiatric disease.

Discover mental health·2023
Same author

A network paradigm predicts drug synergistic effects using downstream protein-protein interactions.

CPT: pharmacometrics & systems pharmacology·2022
Same author

Controlling astrocyte-mediated synaptic pruning signals for schizophrenia drug repurposing with deep graph networks.

PLoS computational biology·2022